Diligence the item, the history, the licences, and the foreign-list overlay before signing.
Ask what the target exported (goods and technology), to whom, with which China licences, and whether catch-all red flags were ignored. Review classification memos, MOFCOM correspondence, customs holds, and ICP reality versus the binder. Map US-origin content, US-person involvement, and EU dual-use if the group touches those systems. Unreliable Entity List, AFSL exposure, and pending investigations belong in the same workstream. SPA warranties are not a substitute for a look-back; they allocate known risk. Integration must freeze risky shipments on day one. Verify current lists at signing and closing — they move.
4 questions before you choose the route.
This page identifies the right question and evidence. It does not determine the legal outcome on a reader’s facts.
What does the target actually make and send abroad?
SKUs, tech, remote support, engineers.
ScopeIs there a real classification and licence register?
Dated memos vs folklore.
FileAny government touch in the look-back?
Queries, denials, seizures, penalties.
HistoryWhat foreign-law overlay travels with the deal?
EAR, EU, owner nationality.
StackWorking rule: Map the regulated role before marketing or launch in China.
The signal ledger.
These facts move the question beyond a label and into a product, money-flow and control analysis.
Bring a compact evidence docket—not a pitch deck.
Give a compliance team or counsel the operating facts that reveal the perimeter.
Questions people ask before they build.
Short answers for orientation. The right result can change with the service model and current rules.
Can we close and fix licences after?
Past unlicensed exports are not cured by a post-closing ICP. Price, holdback, or walk. Do not treat it as a day-two chore.
Is this only for defence targets?
No. Minerals, machine tools, software, and ordinary factories with a military customer all show up in China M&A.
Primary authorities
Reviewed sources support orientation, not a fact-specific assessment.